Veoli

Company Overview

Snapshot

Founded in December 2018 by Tzur Di-Cori, Veoli operates with 1–10 employees. The company has raised $650,000 across two funding rounds from two investors. In August 2019, Merchavia Holdings invested in the company.

Business overview

Veoli is developing an inhaler that enables patients to use cannabis oil at an accurate dosage without the need for heat, evaporation, or burning. Its core technology is based on a device that converts liquid into micron-sized droplets for inhalation and absorption into the lungs. The company serves the medical cannabis market within the Health Tech & Life Sciences sector, focusing on drug delivery and medical devices.

Strategic signal

In August 2019, Merchavia Holdings completed an investment in Veoli, as reported by en.globes.co.il. This signals investor confidence in Veoli's innovative cannabis oil inhaler technology and its potential to address the growing demand for precise and heat-free cannabis delivery methods in the medical sector.

Company Intelligence Q&A

What is Veoli's primary product?

Veoli's primary product is an inhaler designed for the accurate dosage of cannabis oil without requiring heat, evaporation, or burning.

When was Veoli founded?

Veoli was founded in December 2018.

Who is the founder of Veoli?

Tzur Di-Cori is the founder and CEO of Veoli.

What was a key investment milestone for Veoli?

In August 2019, Merchavia Holdings made an investment in Veoli, contributing to the company's total of $650,000 raised across two funding rounds.

What is Veoli's status as of August 2021?

Veoli ceased to operate in August 2021.